RNA, 7SL, cytoplasmic 471, pseudogene: A promising drug target and biomarker

Target Name: RN7SL471P

NCBI ID: G106481051

RN7SL471P

Other Name(s): RNA, 7SL, cytoplasmic 471, pseudogene | RN7SL257P | RNA, 7SL, cytoplasmic 257, pseudogene

RNA, 7SL, cytoplasmic 471, pseudogene: A promising drug target and biomarker

RNA-based technologies have revolutionized the field of genetics and have led to the discovery of many pseudogenes, which are genes that have been preserved in the genomic DNA but have not been transcribed into RNA. One of these pseudogenes, RNA, 7SL, cytoplasmic 471, pseudogene (RNA7SL471P), has shown promising potential as a drug target and biomarker.

RNA7SL471P is a 7-slash RNA molecule that contains 471 base pairs of RNA. It is located in the cytoplasm of human cells and has been identified using various techniques such as transcriptomics, RNA sequencing, and bioinformatics analysis. RNA7SL471P is unique because it has a single-stranded structure and is not a typical double-stranded RNA molecule, as its complementary base pairs are not covalently bound to each other.

TheRNA7SL471P has been shown to play a crucial role in various cellular processes, including cell signaling, DNA replication, and gene regulation. It has been shown to be involved in the regulation of cell adhesion, a process that is essential for the maintenance of tissue structure and function. RNA7SL471P has also been shown to be involved in the regulation of cell cycle progression, which is critical for the development and maintenance of cancer cells.

As a potential drug target, RNA7SL471P has been studied for its ability to interact with various signaling pathways. For example, RNA7SL471P has been shown to interact with the protein kinase B-complex, which is involved in cell signaling. This interaction may play a role in the regulation of cellular processes that are altered in cancer cells, such as cell division, angiogenesis, and drug resistance.

In addition to its potential role as a drug target, RNA7SL471P has also been shown to be a potential biomarker. The cytoplasmic distribution of RNA7SL471P makes it a unique protein that can be used to study the localization of proteins in cells. This information can be used to gain insights into the functions of different proteins and their roles in various cellular processes.

RNA7SL471P has also been shown to be involved in the regulation of cellular processes that are critical for the development and maintenance of diseases, such as cancer. For example, RNA7SL471P has been shown to be involved in the regulation of cell division in cancer cells, which is critical for the development of cancer stem cells.

In conclusion, RNA7SL471P is a promising drug target and biomarker that has the potential to contribute to the development of new therapies for various diseases. Further research is needed to fully understand the functions of RNA7SL471P and its potential as a drug target and biomarker.

Protein Name: RNA, 7SL, Cytoplasmic 471, Pseudogene

The "RN7SL471P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RN7SL471P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets